(Hypertension. 1996;28:810-817.)
© 1996 American Heart Association, Inc.
Articles |
the Department of Medicine II, Kansai Medical University, Osaka, Japan, and the Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tenn (T.H., T. Inagami).
The cDNA sequence of rat angiotensin II type 1A receptor (AT1AR) shows that AT1AR transcripts have AUG triplets in the 5'-leader region that may begin a short open reading frame encoding an 11amino acid peptide. In this study, the mutational inactivation of the start codon of the short open reading frame in AT1ARchloramphenicol acetyltransferase (CAT) reporter gene constructs resulted in a 2.6-fold increase in CAT activity, whereas CAT transcript levels were not affected. Furthermore, experiments with rat AT1AR cDNAtransfected Cos-7 cells revealed that mutagenesis of the upstream AUG increased the AT1AR protein up to 2.5-fold, although AT1AR transcript levels showed no changes. The synthetic peptide corresponding to the sequence of the short open reading frame significantly suppressed the amount of AT1AR product in the in vitro translation system. The inhibiting effect of the short open reading frame appears to operate at least in part at the level of translation initiation, because polysome analysis with transfected Cos-7 cells showed that mutagenesis of the upstream AUG resulted in a shift of AT1AR mRNA distribution from a smaller to larger fraction of polysomes. Taken together, these results show that the upstream AUG inhibits translational regulation, suggesting that the short open reading frame in the 5'-leader region of AT1AR transcripts has a certain role in the translation of AT1AR protein.
Key Words: receptors, angiotensin II molecular biology muscle, smooth, vascular genes rats
This article has been cited by other articles:
![]() |
T. S. Elton and M. M. Martin Angiotensin II Type 1 Receptor Gene Regulation: Transcriptional and Posttranscriptional Mechanisms Hypertension, May 1, 2007; 49(5): 953 - 961. [Full Text] [PDF] |
||||
![]() |
C. Rabadan-Diehl, S. Volpi, M. Nikodemova, and G. Aguilera Translational Regulation of the Vasopressin V1b Receptor Involves an Internal Ribosome Entry Site Mol. Endocrinol., October 1, 2003; 17(10): 1959 - 1971. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gereben, A. Kollar, J. W. Harney, and P. R. Larsen The mRNA Structure Has Potent Regulatory Effects on Type 2 Iodothyronine Deiodinase Expression Mol. Endocrinol., July 1, 2002; 16(7): 1667 - 1679. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Xu, C. Rabadan-Diehl, M. Nikodemova, P. Wynn, J. Spiess, and G. Aguilera Inhibition of Corticotropin Releasing Hormone Type-1 Receptor Translation by an Upstream AUG Triplet in the 5' Untranslated Region Mol. Pharmacol., March 1, 2001; 59(3): 485 - 492. [Abstract] [Full Text] |
||||
![]() |
L. A. Goldstein and W.-T. Chen Identification of an Alternatively Spliced Seprase mRNA That Encodes a Novel Intracellular Isoform J. Biol. Chem., January 28, 2000; 275(4): 2554 - 2559. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tsutsumi, H. Matsubara, N. Ohkubo, Y. Mori, Y. Nozawa, S. Murasawa, K. Kijima, K. Maruyama, H. Masaki, Y. Moriguchi, et al. Angiotensin II Type 2 Receptor Is Upregulated in Human Heart With Interstitial Fibrosis, and Cardiac Fibroblasts Are the Major Cell Type for Its Expression Circ. Res., November 16, 1998; 83(10): 1035 - 1046. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |